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Results of studies performed in our center point at DNA
changes of many cancer (mostly moderate) susceptibility
genes. Association of “weak” mutations and polymorph-
ism of many genes and additional influence of environ-
mental factors can significantly increase the risk of
cancer development.
The preliminary studies performed in our department
indicate, that increased risk of gastric cancer may be
r e l a t e dt om u t a t i o ni nN O D 2a n dC H K 2g e n e sp r e d i s -
posing to cancers of many organs.
The CHEK2 gene encodes checkpoint kinase 2 (Chk2),
it acts as a tumor suppressor whose functions are central
to the induction of cell cycle arrest and apoptosis by
DNA damage.
Results of studies performed in our center indicate that
the frequency of the IVS2+1G®A alteration was signifi-
cantly increased in a group of 658 consecutive patients,
especially in those under 50 years of age (OR=5.332,
p=0.0174). I157T was over-represented in the group of
familial gastric cancer patients, particularly in patients
diagnosed at less than 50 years of age (OR=3.687,
p=0.0011) and females. The specific group of intestinal
and mixed histopathological subtype occurs more fre-
quently (OR=1.671) in consecutive carriers of I157T
mutation.
Recently, the NOD2/CARD15, gene located on chromo-
some 16q12, has been associated with Crohn’s disease. It
is believed to play a role both in intracellular recognition
of lipopolysaccharides (LPS) typical of Gram negative bac-
teria and subsequent activation of NFkB. 3020insC NOD2
mutation causes an increased risk of developing chronic
inflammatory diseases of the gastrointestinal tract and
colorectal cancer in their course. In light of recent studies,
in fact 3020insC mutation predisposes to cancers of many
organs, including breast, ovarian, lung. Studies conducted
in our center in the group of 103 patients with a family
history of gastric cancer, have shown that NOD2
3020insC carriers in persons over 50 y of age more than
doubled (OR=2.479, p=0.022) and among women almost
3-fold increased risk. In addition, NOD2 R702W alteration
occurred almost three times more frequently (OR=2.816,
p=0.0121) in the group of 241 consecutive patients with
gastric cancer diagnosed before 50 years of age and over
2-times frequently (OR=2.268, p=0.0371) in gastric cancer
selected histopathologically as intestinal type according to
Lauren.
There are a large number of reports describing the
relationship between changes in the gene TP53, particu-
larly polimomorfizm Arg72Pro, and risk of gastric cancer.
Many researchers have found links between gene poly-
morphism of Interleukin-1, and the risk of stomach can-
cer. Gene polymorphism of angiotensin converting
enzyme ACE, was recently linked with the pathogenesis
and development of human cancers. Research Ebert MP,
et al. conducted in a group of 88 patients shows that the
insertion / deletion ACE gene may be associated with the
development of early gastric cancer in the German popu-
lation. In the Japanese population genetically distant,
however, found no relationship between gastric cancer
and ACE gene polymorphism). Sentences on the ACE
polymorphism and risk of stomach cancer researchers
are divided among different centers.
XRCC1 gene is part of composite protein complex con-
taining the ß-polymerase DNA ligase I and PARP (poly-
merase poly (ADP-ribose). This multi-unit complex is
involved in DNA repair pathway. T. Poplawski et al. indi-
cate that the variant Gln / Gln XRCC1 gene polymorph-
ism Arg399Gly occurred more frequently in patients with
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3,29) and the results obtained from studies in the group of
152 patients with a family history of gastric cancer suggest
that gene XRCC1 399Gln allele may be considered a mar-
ker of gastric cancer.
In terms of predisposition to gastric cancer has also been
studied recently LAPTM4B gene associated with a genetic
predisposition to liver cancer, having LAPTM4B alleles * 1
and LAPTM4B * 2. The risk of stomach cancer was
increased 1.819 times in patients with genotype * 1 / 2
(CI=1.273-2.601) and 2.387 times in patients with geno-
type * 2 / 2 LAPTM4B (CI=1.195-4.767) compared with
genotype * 1 / first. These studies indicate that allele * 2
LAPTM4B may be one of the genetic factors of gastric
cancer.
Further studies of newly described mutation moder-
ately increased risk of stomach cancer may allow to esti-
mate the real risk of gastric cancer associated with these
mutations in the Polish population.
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